Nitropress (Valeant Pharmaceuticals North America LLC)
Welcome to the PulseAid listing for the Nitropress drug offered from Valeant Pharmaceuticals North America LLC. This Vasodilation [PE],Vasodilator [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Valeant Pharmaceuticals North America LLC |
NON-PROPRIETARY NAME: | sodium nitroprusside |
SUBSTANCE NAME: | SODIUM NITROPRUSSIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Vasodilation [PE],Vasodilator [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION, CONCENTRATE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2013-12-01 |
END MARKETING DATE: | 0000-00-00 |
Nitropress HUMAN PRESCRIPTION DRUG Details:
Item Description | Nitropress from Valeant Pharmaceuticals North America LLC |
LABELER NAME: | Valeant Pharmaceuticals North America LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50(mg/2mL) |
START MARKETING DATE: | 2013-12-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0187-4302_fd76b793-d446-4d22-b905-aa981c0b5bf3 |
PRODUCT NDC: | 0187-4302 |
APPLICATION NUMBER: | ANDA071961 |
Other SODIUM NITROPRUSSIDE Pharmaceutical Manufacturers / Labelers: